Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant LAG3 antibody

The Rat Monoclonal anti-LAG3 antibody has been validated for IP, FACS and BP. It is suitable to detect LAG3 in samples from Mouse.
Catalog No. ABIN7072736

Quick Overview for Recombinant LAG3 antibody (ABIN7072736)

Target

See all LAG3 Antibodies
LAG3 (Lymphocyte-Activation Gene 3 (LAG3))

Antibody Type

Recombinant Antibody

Reactivity

  • 107
  • 33
  • 9
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
Mouse

Host

  • 56
  • 48
  • 6
  • 4
  • 2
  • 1
Rat

Clonality

  • 61
  • 53
  • 2
Monoclonal

Conjugate

  • 63
  • 8
  • 6
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This LAG3 antibody is un-conjugated

Application

  • 73
  • 41
  • 36
  • 34
  • 28
  • 24
  • 15
  • 13
  • 13
  • 11
  • 9
  • 9
  • 5
  • 2
  • 2
  • 1
  • 1
  • 1
Immunoprecipitation (IP), Flow Cytometry (FACS), Blocking Peptide (BP)

Clone

C9B7W
  • Purpose

    Anti-LAG-3 [C9B7W], Rat IgG1, kappa

    Specificity

    This antibody is specific for an epitope in the D2 domain of murine LAG-3.

    Characteristics

    Original Species of Ab: Rat

    Original Format of Ab: IgG1

    Purification

    Protein A affinity purified

    Immunogen

    This antibody was raised by immunising Lewis rats with a murine LAG-3:Ig fusion protein.

    Isotype

    IgG1 kappa
  • Application Notes

    This antibody has been used in flow cytometric analysis of splenocytes (Workman et al, 2005), T cell hybridomas expressing wild-type or chimeric CD4:murine LAG-3 (Workman et al, 2002) and CD4+ regulatory T cells (Chien et al, 2017). It has also been used in immunoprecipitation analysis of murine T hybridoma 3A9 cells transduced with murine LAG-3 (Li et al, 2004). This antibody blocks LAG-3 function in vitro, inhibiting antigen-induced IL-2 production in LAG-3-expressing T cell hybridomas, but does not block LAG-3:MHC class II interaction (Workman et al, 2002). Treatment with this antibody also blocks LAG-3 function in vivo, leading to accelerated homeostatic expansion of WT T cells (Workman et al, 2005). Administration of this LAG-3-blocking antibody, in combination with PD-L1 blockade, synergistically improves the survival of lymphodepleted myeloma-bearing mice (Jing et al, 2015).

    Restrictions

    For Research Use only
  • Concentration

    1 mg/mL

    Buffer

    PBS with 0.02 % Proclin 300.

    Preservative

    ProClin

    Precaution of Use

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Storage Comment

    Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
  • Target

    LAG3 (Lymphocyte-Activation Gene 3 (LAG3))

    Alternative Name

    Lag3

    Background

    CD223, LAG3, Lymphocyte activation gene 3 protein

    UniProt

    Q61790

    Pathways

    Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
You are here:
Chat with us!